Maillard Reaction-Mediated Molecular Damage to Extracellular Matrix and Other Tissue Proteins in Diabetes, Aging, and Uremia
The DOI matches its Crossref record.
Abstract
Recent progress in structure elucidation of products of the advanced Maillard reaction now allows probing specifically for the role of this reaction in the pathogenesis of age- and diabetes-related complications. Pyrraline is a glucose-derived advanced glycation end product against which polyclonal and monoclonal antibodies have been raised. Immunohistochemical localization studies revealed that pyrraline is found predominantly in the sclerosed extracellular matrix of glomerular and arteriolar renal tissues from both diabetic and aged nondiabetic individuals. Pentosidine and carboxymethyllysine are Maillard end products derived from both glucose and ascorbate. In addition, pentosidine can be formed from several other sugars under oxidative conditions, and in vitro studies suggest that a common intermediate involving a pentose is a necessary precursor molecule. The highest levels of these advanced Maillard products are generally found in the extracellular matrix, but these products are also present in lens proteins and in proteins with a fast turnover such as plasma proteins. Diabetes, and especially uremia, greatly catalyzes pentosidine formation. Both conditions are characterized by accelerated cataractogenesis, atherosclerosis, and neuropathy, suggesting that molecular damage by advanced Maillard reaction products may be a common mechanism in their development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Advanced oxidation protein products as a novel marker of oxidative stress in uremia
Witko-Sarsat, V., Friedlander, M., Capeillère-Blandin, C., Nguyen-Khoa, T., Nguyen, A. T., Zingraff, J., Jungers, P., & Descamps-Latscha, B. (1996) · Kidney International · doi:10.1038/ki.1996.186 · Cited by 1,999
Advanced glycation endproducts—role in pathology of diabetic complications
Ahmed, N. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.09.004 · Cited by 1,455
Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products
Verzijl, N., DeGroot, J., Thorpe, S. R., Bank, R. A., Shaw, J. N., Lyons, T. J., Bijlsma, J. W. J., Lafeber, F. P. J. G., Baynes, J. W., & TeKoppele, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006700200 · Cited by 963
Carr, A. C., & Frei, B. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1086 · Cited by 940
Witko-Sarsat, V., Friedlander, M., Khoa, T. N., Capeillère-Blandin, C., Nguyen, A. T., Canteloup, S., Dayer, J.-M., Jungers, P., Drüeke, T., & Descamps-Latscha, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2524 · Cited by 878
Age-related changes in the collagen network and toughness of bone
Wang, X., Shen, X., Li, X., & Mauli Agrawal, C. (2002) · Bone · doi:10.1016/s8756-3282(01)00697-4 · Cited by 777
Diabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
Oxidant Mechanisms in Renal Injury and Disease
Ratliff, B. B., Abdulmahdi, W., Pawar, R., & Wolin, M. S. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6665 · Cited by 694
The pathogenesis of tendinopathy. A molecular perspective
Riley, G. (2004) · Rheumatology · doi:10.1093/rheumatology/keg448 · Cited by 543
TANJI, N., MARKOWITZ, G. S., FU, C., KISLINGER, T., TAGUCHI, A., PISCHETSRIEDER, M., STERN, D., SCHMIDT, A. M., & D'AGATI, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191656 · Cited by 487
Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants
Tanaka, Y., Gleason, C. E., Tran, P. O. T., Harmon, J. S., & Robertson, R. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10857 · Cited by 459
Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V. M., Witztum, J. L., & Kurokawa, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119853 · Cited by 433
Self-citationHyperglycemia and Glycation in Diabetic Complications
Negre-Salvayre, A., Salvayre, R., Augé, N., Pamplona, R., & Portero-Otín, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2484 · Cited by 421
Riley, G. P., Curry, V., DeGroot, J., van El, B., Verzijl, N., Hazleman, B. L., & Bank, R. A. (2002) · Matrix Biology · doi:10.1016/s0945-053x(01)00196-2 · Cited by 378
Miyata, T., Wada, Y., Cai, Z., Iida, Y., Horie, K., Yasuda, Y., Maeda, K., Kurokawa, K., & De Strihou, C. V. Y. (1997) · Kidney International · doi:10.1038/ki.1997.160 · Cited by 352
Age-related accumulation of Maillard reaction products in human articular cartilage collagen
Verzijl, N., DeGroot, J., OLDEHINKEL, E., Bank, R. A., Thorpe, S. R., Baynes, J., Bayliss, M. T., Bijlsma, J. W. J., Lafeber, F. P. J. G., & TeKoppele, J. M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3500381 · Cited by 345
Diabetes and Advanced Glycoxidation End Products
Huebschmann, A. G., Regensteiner, J. G., Vlassara, H., & Reusch, J. E. B. (2006) · Diabetes Care · doi:10.2337/dc05-2096 · Cited by 330
Protein Cross-linking by the Maillard Reaction
Nagaraj, R. H., Shipanova, I. N., & Faust, F. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19338 · Cited by 304
Self-citationBody temperature regulation in diabetes
Kenny, G. P., Sigal, R. J., & McGinn, R. (2016) · Temperature · doi:10.1080/23328940.2015.1131506 · Cited by 297
“, diabetes tends to accelerate any age-related changes).(45,147)”
BackgroundAdvanced glycation end products: A nephrologist's perspective
Raj, D. S. C., Choudhury, D., Welbourne, T. C., & Levi, M. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70189-2 · Cited by 290
Microtubule-Associated Protein Tau
Yen, S.-H., Nacharaju, P., Ko, L.-W., Kenessey, A., & Liu, W.-K. (1998) · Handbook of the Aging Brain · doi:10.1016/b978-012734610-6/50012-9 · Cited by 282
Miyata, T., Ueda, Y., Shinzato, T., Iida, Y., Tanaka, S., Kurokawa, K., van Ypersele de Strihou, C., & Maeda, K. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v781198 · Cited by 232
Oppermann, U. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105316 · Cited by 220
Advanced glycation end products, diabetes, and bone strength
Yamamoto, M., & Sugimoto, T. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0332-1 · Cited by 215
Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification
Schalkwijk, C. G., Stehouwer, C. D. A., & van Hinsbergh, V. W. M. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.488 · Cited by 206
Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products
Zheng, F., He, C., Cai, W., Hattori, M., Steffes, M., & Vlassara, H. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.283 · Cited by 206
Faist, V., & Erbersdobler, H. F. (2001) · Annals of Nutrition and Metabolism · doi:10.1159/000046699 · Cited by 192
Soulis, T., Cooper, M. E., Vranes, D., Bucala, R., & Jerums, G. (1996) · Kidney International · doi:10.1038/ki.1996.358 · Cited by 158
“Advanced glycation end-products (AGEs) accumulate over time on long-lived proteins including lens crystallin [1] and skin collagen [2, 3].”
BackgroundYoshida, N., Okumura, K.-I., & Aso, Y. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.014 · Cited by 138
“Free pentosidine, with a relative molecular weight of 379 d, can be synthesized through nonenzymatic reactions of pentoses such as ribose, xylose, arabinose, and lyxose with l-lysine, l-arginine, or collagen [5].”
BackgroundNyman, J. S., Even, J. L., Jo, C.-H., Herbert, E. G., Murry, M. R., Cockrell, G. E., Wahl, E. C., Bunn, R. C., Lumpkin, C. K., Fowlkes, J. L., et al. (2011) · Bone · doi:10.1016/j.bone.2010.12.016 · Cited by 112
“Given the potential anabolic effects of insulin on bone [19] and the role of glucose in the formation of advanced glycation end-products (AGEs) [20], diabetes likely affects both bone structure and tissue integrity of bone.”
Background
Metadata
- Authors
- Monnier, V. M., Sell, D. R., Nagaraj, R. H., Miyata, S., Grandhee, S., Odetti, P., & Ibrahim, S. A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1992-10-01
- Volume
- 41
- Issue
- Supplement_2
- Pages
- 36-41
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2138200625
- Cited by
- 309
- References
- 0
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.